We are live on ! Find out more
ACM

Asymmetry Capital Management Portfolio holdings

AUM $188M
1-Year Est. Return 44.72%
This Fund
S&P 500
This Quarter Est. Return
+24.05%
1 Year Est. Return
+44.72%
3 Year Est. Return
+299.95%
5 Year Est. Return
+628.83%
10 Year Est. Return
–
AUM
$59.8M
AUM Growth
+$23.6M
Cap. Flow
+$14.7M
Cap. Flow %
24.55%
Top 10 Hldgs %
72.36%
Holding
33
New
10
Increased
11
Reduced
3
Closed
8

Top Buys

Rank Stock Value
1
INGN icon
Inogen
INGN
+$5.43M
2
GILD icon
Gilead Sciences
GILD
+$4.64M
3
MYOK
MyoKardia, Inc. Common Stock
MYOK
+$2.88M
4
ILMN icon
Illumina
ILMN
+$2.49M
5
CNC icon
Centene
CNC
+$1.62M

Top Sells

Rank Stock Value
1
INSM icon
Insmed
INSM
+$5.66M
2
INCY icon
Incyte
INCY
+$2.01M
3
NBIX icon
Neurocrine Biosciences
NBIX
+$1.47M
4
DVA icon
DaVita
DVA
+$1.09M
5
GBT
Global Blood Therapeutics, Inc.
GBT
+$1.03M

Sector Composition

Rank Sector Weight
1 Healthcare 82.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BIO icon
26
Bio-Rad Laboratories Class A
BIO
$9.42B
– –
-1,745
Closed -$405K
DRRX
27
DELISTED
DURECT Corp
DRRX
– –
-22,882
Closed -$111K
DVA icon
28
DaVita
DVA
$11.7B
– –
-21,156
Closed -$1.09M
EQ icon
29
Equillium
EQ
$133M
– –
-60,882
Closed -$497K
FOLD
30
DELISTED
Amicus Therapeutics
FOLD
– –
-97,294
Closed -$932K
INCY icon
31
Incyte
INCY
$24.4B
– –
-31,588
Closed -$2.01M
NBIX icon
32
Neurocrine Biosciences
NBIX
$16.6B
– –
-20,571
Closed -$1.47M
KDMN
33
DELISTED
Kadmon Holdings, Inc.
KDMN
– –
-192,637
Closed -$401K
1
2

Similar funds

FAC
Forrestal Agricultural Corporation Princeton, New Jersey $183M AUM
SWM
Strategic Wealth Management Kirkland, Washington $202M AUM 9.35% 1-Year Est. Return
MC
MRJ Capital New York $173M AUM 31.99% 1-Year Est. Return
KM
Kylin Management New York $173M AUM 39.51% 1-Year Est. Return
TI
Truehand Inc Strafford, New Hampshire $171M AUM 25.9% 1-Year Est. Return
GC
Grace Capital Quincy, Massachusetts $168M AUM 21.6% 1-Year Est. Return
REMS
Real Estate Management Services $167M AUM 37.69% 1-Year Est. Return
NM
Nokota Management New York $165M AUM

Asymmetry Capital Management's Q1 2019 Portfolio in Review

As of Q1 2019, Asymmetry Capital Management held 33 positions worth $59.8M, up 65% from $36.2M the previous quarter. Its ten largest holdings account for 72% of the portfolio.

Asymmetry Capital Management deployed $14.7M of net new capital in Q1 2019, opening 10 new positions and adding to 11 existing holdings. Its largest new stake was Gilead Sciences: 69,879 shares worth $4.54M.

By sector, the portfolio is most concentrated in Healthcare at 83% of assets, down from 83% a quarter earlier.

On the sell side, the largest reduction was Insmed, an estimated $5.66M trimmed.

  • Asymmetry Capital Management's largest Q1 2019 buy was Gilead Sciences: 69,879 shares worth $4.54M.
  • Asymmetry Capital Management added most to Inogen in Q1 2019, an estimated $5.43M increase.
  • Asymmetry Capital Management's biggest Q1 2019 reduction was Insmed, cutting an estimated $5.66M.
  • Asymmetry Capital Management fully exited Incyte in Q1 2019, selling an estimated $2.01M.
  • Asymmetry Capital Management's ten largest holdings make up 72% of its $59.8M portfolio in Q1 2019.
  • Asymmetry Capital Management opened 10 new positions and closed 8 in Q1 2019.
  • Asymmetry Capital Management's portfolio value rose 65% quarter-over-quarter to $59.8M.

Based on Asymmetry Capital Management's 13F filing for Q1 2019, filed 8 May 2019.